SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia

Status unconfirmed · Phase 2

Conditions studied: Precancerous Condition

In brief

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of or treat early cancer. SGN-00101 may be effective in preventing the development of cervical cancer in patients with cervical intraepithelial neoplasia. PURPOSE: This randomized phase II trial is studying how well SGN-00101 works in preventing cervical cancer in patients with cervical intraepithelial neoplasia and human papillomavirus.

Key facts

Study ID

NCT00060099

Run by

Dana-Farber/Brigham and Women's Cancer Center

Starts

2003-05-01

Last updated by the study team

2013-11-06

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Brigham and Women's Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.